Drew Moghanaki: There is more than one way to think about how lung cancers develop
Drew Moghanaki shared a post on X:
“These figures shared by Steve Dubinett at UCLA provide a reminder that there is more than one way to think about how lung cancers develop. This is why early detection biomarkers should ideally include evaluations of individual immunosurveillance properties in addition to circulating tumor markers.”
Source: Drew Moghanaki/X
Dr. Drew Moghanaki, a Professor and Chief of Thoracic Oncology at the Department of Radiation Oncology, UCLA. He holds the Stanley Iezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research at the same university.
He specializes in treating lung cancer and other thoracic malignancies, focusing on advanced radiation therapy techniques like stereotactic body radiation therapy (SBRT), magnetic resonance-guided radiation therapy (MRgRT), and intensity-modulated radiation therapy (IMRT).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023